Intact indoleamine 2,3-dioxygenase activity in human chronic granulomatous disease
Open Access
- 31 October 2010
- journal article
- research article
- Published by Elsevier BV in Clinical Immunology
- Vol. 137 (1), 1-4
- https://doi.org/10.1016/j.clim.2010.05.007
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- NADPH Oxidase Limits Innate Immune Responses in the Lungs in MicePLOS ONE, 2010
- Reactive oxygen species–independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous diseaseProceedings of the National Academy of Sciences of the United States of America, 2010
- Restoration of NET formation by gene therapy in CGD controls aspergillosisBlood, 2009
- Cytochrome b5, Not Superoxide Anion Radical, Is a Major Reductant of Indoleamine 2,3-Dioxygenase in Human CellsOnline Journal of Public Health Informatics, 2008
- Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous diseaseNature, 2008
- Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS‐independent activation of NF‐κBEuropean Journal of Immunology, 2007
- The role of indoleamine 2,3-dioxygenase in transplantationTransplant International, 2007
- Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsisJCI Insight, 2006
- Ido expression by dendritic cells: tolerance and tryptophan catabolismNature Reviews Immunology, 2004
- Tolerance, DCs and tryptophan: much ado about IDOTrends in Immunology, 2003